Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Mycol Med ; 30(3): 100966, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-32317216

RESUMEN

Candida africana has been recovered principally as a causative agent of vulvovaginal candidiasis (VVC) from different countries, which is likely to be misidentified as the typical Candida albicans or Candida dubliniensis. The current study aimed to characterize C. albicans species complex obtained from VVC based on conventional and molecular assays. Furthermore, in vitro antifungal susceptibility testing was performed based on CLSI documents. Additionally, due to low knowledge concerning C. africana infections, we reviewed all published papers from 1991 to 2019. One hundred forty-four out of 287 patients were identified with Candida infection, among whom 151 isolates of Candida were obtained. Candida albicans 109 (72.1%), Candida glabrata 21 (13.9%), Candida krusei 8 (5.2%), Candida tropicalis 5 (3.3%), Candida africana 3 (1.9%), Candida parapsilosis 3 (1.9%) and C. dubliniensis 2 (1.3%) were isolated from patients. MIC results showed that C. africana isolates were susceptible to all tested antifungal drugs. Candida africana infections were more prevalent in Africa. One hundred fifteen (40.6%) of patients with C. africana candidiasis were from seven African countries, and Madagascar and Angola had the majority of cases. The epidemiological data, phenotypic, clinical features, ecologic similarity, and antifungal susceptibility profiles for better understanding of the pathogenic mechanisms and optimal treatment underlying non-CandidaalbicansCandida vulvovaginitis are highly recommended.


Asunto(s)
Candida/aislamiento & purificación , Candidiasis Vulvovaginal/epidemiología , Candidiasis Vulvovaginal/microbiología , África/epidemiología , Antifúngicos/uso terapéutico , Candida/clasificación , Candida/efectos de los fármacos , Candidiasis Vulvovaginal/tratamiento farmacológico , Femenino , Geografía , Historia del Siglo XX , Historia del Siglo XXI , Humanos , Madagascar/epidemiología , Pruebas de Sensibilidad Microbiana , Prevalencia
2.
J Mycol Med ; 28(4): 599-605, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30322827

RESUMEN

OBJECTIVE: Cryptococcosis is a major opportunistic fungal infection caused by members of the genus Cryptococcus, mainly those belonging to the Cryptococcus neoformans/Cryptococcus gattii species complexes. Here, we report a comprehensive molecular epidemiological study of the environmental distribution of Cryptococcus isolates in Shiraz, Iran with review of litreature. METHOD: A total of 406 samples were obtained from Eucalyptus trees and 139 samples from pigeon droppings. Cryptococcus species identification and genotyping were performed by amplified fragment length polymorphism (AFLP) fingerprinting sequencing and sequencing of the ITS rDNA region. RESULTS: Majority of the isolates belonged to the Naganishia taxon (n=69) including N. albida (formerly C. albidus, n=62), N. globosa (formerly C. saitoi, n=4), N. adeliensis (formerly C. adeliensis, n=2), N. diffluens (formerly C. diffluens, n=1), and the identified C. neoformans isolates (n=25) belonged to genotype AFLP1/VNI (n=22) and AFLP1B/VNII (n=3). CONCLUSION: More research efforts should be employed to isolate C. gattii species complex from environmental niches in Iran and provide additional evidence related to novel molecular types.


Asunto(s)
Cryptococcus/clasificación , Cryptococcus/genética , Microbiología Ambiental , Epidemiología Molecular , Análisis del Polimorfismo de Longitud de Fragmentos Amplificados , Animales , Columbidae/microbiología , Cryptococcus/aislamiento & purificación , ADN de Hongos/genética , ADN Espaciador Ribosómico/genética , Eucalyptus/microbiología , Genoma Fúngico/genética , Genotipo , Irán/epidemiología , Tipificación Molecular , Técnicas de Tipificación Micológica , Polimorfismo de Longitud del Fragmento de Restricción , Análisis de Secuencia de ADN
3.
J Mycol Med ; 28(1): 59-64, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29496370

RESUMEN

Tricyclazole as a common fungicide wildly used to control rice blast disease in the Asian country may induce azole resistance in Aspergillus fumigatus isolates. The main reason of the acquired azole resistance is probably environmental exposure through wide fungicide use in agriculture. The present study was conducted with the aim of investigating the current status of the azole-resistant A. fumigatus obtained from the paddy fields with exposure to tricyclazole. A total of 108 soil samples were collected from four different locations of paddy fields in Mazandaran Province, Iran. Pure fungal colonies were initially identified based on the conventional tools, and then reconfirmed by using DNA sequencing of the partial ß-tubulin gene. In addition, the in vitro antifungal susceptibility was determined using the Clinical and Laboratory Standards Institute document (CLSI) M38-A2. The identification of the mutations in the CYP51A gene was accomplished by the implementation of the polymerase chain reaction amplification assay on the selected isolates. Overall, 31 of 108 (28.7%) isolates were identified as A. fumigatus, four (3.7%) of which were recognized as azole-resistant with MICs of itraconazole ≥8µg/ml and voriconazole ≥4µg/ml. Only two out of the four azole-resistant A. fumigatus isolates harboured TR34/L98H variant and the other two isolates were identified as azole-resistant without any CYP51A gene mutations. However, other point mutations (TR46/Y121F/T289A) were not detected in the CYP51A gene. The high molecular structure similarity between environmental and medical triazoles may result in the selection of resistance mechanisms. Nonetheless, one might conclude that tricyclazole with different molecular structures against medical azoles induces azole-resistance in A. fumigatus isolates. The behavior of such pesticides as tricyclazole in the rice paddy fields would have an effective role in the development of azole-resistance that requires detailed information.


Asunto(s)
Aspergillus fumigatus/efectos de los fármacos , Azoles/farmacología , Farmacorresistencia Fúngica , Oryza/microbiología , Plaguicidas/farmacología , Tiazoles/farmacología , Agricultura/métodos , Antifúngicos/farmacología , Aspergillus fumigatus/aislamiento & purificación , Sistema Enzimático del Citocromo P-450/genética , Proteínas Fúngicas/genética , Hongos/efectos de los fármacos , Hongos/aislamiento & purificación , Genes Fúngicos/genética , Genotipo , Humanos , Irán , Itraconazol/farmacología , Pruebas de Sensibilidad Microbiana , Oryza/efectos de los fármacos , Plaguicidas/química , Plaguicidas/metabolismo , Análisis de Secuencia de ADN , Suelo/química , Microbiología del Suelo
4.
J Mycol Med ; 27(2): 146-152, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28318900

RESUMEN

To date, there has been no comprehensive review of the epidemiology, risk factors, species distribution, and outcomes of candidemia in Iran. This study aimed to perform a systematic review and meta-analysis of all reported candidemia cases in Iran until December 2015. The review process occurred in three steps, namely a literature search, data extraction and statistical analyses. After a comprehensive literature search, we identified 55 cases. The mean age of patients was 46.80±24.30 years (range 1-81 years). The main risk factors for candidemia were surgery and burns (23.6%), followed by malignancies (20%), use of broad-spectrum antibiotics (18.2%), and diabetes (7.3%). Candida parapsilosis (n=17, 30.8%) was the leading agent, followed by Candida albicans (n=15, 27.3%), Candida glabrata (n=10, 18.2%), and Candida tropicalis (n=8, 14.5%). The frequencies of candidemia cases due to C. glabrata, C. parapsilosis, and C. albicans were significantly higher among patients aged>60, 21-40, and 41-60 years, respectively. Comparison of risk factors for candidemia by multiple logistic regression showed that one of the most important risk factors was surgery (OR: 4.245; 95% CI: 1.141-15.789; P=0.031). The outcome was recorded in only 19 cases and 13 of those patients (68.4%) expired. This study confirms that knowledge of the local epidemiology is important when conducting surveillance studies to prevent and control candidemia and will be of interest for antifungal stewardship.


Asunto(s)
Candidemia/epidemiología , Candidemia/microbiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Humanos , Lactante , Irán/epidemiología , Persona de Mediana Edad , Factores de Riesgo , Adulto Joven
5.
J Mycol Med ; 27(2): 261-265, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28188050

RESUMEN

Symptomatic candiduria often occurs in patients with indwelling bladder catheters or immunocompromised host. Isolation of Candida in urine in high-risk patients should primarily be considered as a marker for candidemia. Hematological and genitourinary malignancies are one of the main risk factors associated with Candida urinary tract infections (CUTI). Fluconazole is a choice for initial treatment of CUTI, but it is fluctuate depending on the patient's condition including renal failure, site of urinary infection and Candida species. Poor glomerular filtration is the main disadvantage echinocandins resulting in very low urinary concentrations. Therefore, echinocandins have prohibited their use in CUTI. Up to now, there are only 10 cases reported in the literatures with highly effective echinocandins in CUTI because of high concentrations in the tissue are needed to control invasive fungal disease. Herein, we report a candiduria followed by renal candidiasis caused by Candida albicans in a 6-year-old Iranian male with a history of Wilms tumor in left kidney. Direct examination of urine specimen revealed an infection due to budding yeast cells with numerous pseudohyphae and growths of C. albicans was reconfirmed by sequencing of ITS rDNA region. MICs in increasing order were as follows: caspofungin (0.016µg/ml), voriconazole (0.125µg/ml), amphotericin B (0.25µg/ml), itraconazole (0.5µg/ml) and fluconazole (2µg/ml). It seems that successful treatment with caspofungin owes achieved high renal tissue concentrations that are unrelated to glomerular filtration. In conclusion, predisposing factors for better outcome are more important than treatment of CUTI, therefore, management of UTI is essential for critically patients.


Asunto(s)
Candidiasis/tratamiento farmacológico , Equinocandinas/uso terapéutico , Neoplasias Renales/tratamiento farmacológico , Lipopéptidos/uso terapéutico , Infecciones Urinarias/tratamiento farmacológico , Tumor de Wilms/tratamiento farmacológico , Antifúngicos/uso terapéutico , Candida/aislamiento & purificación , Candidiasis/complicaciones , Candidiasis/orina , Caspofungina , Niño , Humanos , Irán , Neoplasias Renales/complicaciones , Neoplasias Renales/microbiología , Masculino , Resultado del Tratamiento , Infecciones Urinarias/complicaciones , Infecciones Urinarias/microbiología , Tumor de Wilms/complicaciones , Tumor de Wilms/microbiología
6.
Curr Med Mycol ; 1(1): 42-48, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-28680980

RESUMEN

Chronic obstructive pulmonary disease (COPD) is associated with a chronic inflammatory response in airways and lung parenchyma that results in significant morbidity and mortality worldwide. Cigarette smoking considered as an important risk factor plays a role in pathogenesis of disease. Pneumocystis jirovecii is an atypical opportunistic fungus that causes pneumonia in immunosuppressed host, although the low levels of its DNA in patients without signs and symptoms of pneumonia, which likely represents colonization. The increased prevalence of P. jirovecii colonization in COPD patients has led to an interest in understanding its role in the disease. P. jirovecii colonization in these patients could represent a problem for public health since colonized patients could act as a major reservoir and source of infection for susceptible subjects. Using sensitive molecular techniques, low levels of P. jirovecii DNA have been detected in the respiratory tract of certain individuals. It is necessary to elucidate the role of P. jirovecii colonization in the natural history of COPD patients in order to improve the clinical management of this disease. In the current review paper, we discuss P. jirovecii colonization in COPD patients.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...